Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1997 1
1999 2
2000 6
2001 4
2002 6
2003 2
2004 4
2005 2
2006 3
2007 4
2008 10
2009 10
2010 12
2011 19
2012 8
2013 8
2014 13
2015 23
2016 24
2017 23
2018 32
2019 16
2020 33
2021 32
2022 35
2023 25
2024 32
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

355 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Giatsios
Page 1
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.
Skokos D, Waite JC, Haber L, Crawford A, Hermann A, Ullman E, Slim R, Godin S, Ajithdoss D, Ye X, Wang B, Wu Q, Ramos I, Pawashe A, Canova L, Vazzana K, Ram P, Herlihy E, Ahmed H, Oswald E, Golubov J, Poon P, Havel L, Chiu D, Lazo M, Provoncha K, Yu K, Kim J, Warsaw JJ, Stokes Oristian N, Siao CJ, Dudgeon D, Huang T, Potocky T, Martin J, MacDonald D, Oyejide A, Rafique A, Poueymirou W, Kirshner JR, Smith E, Olson W, Lin J, Thurston G, Sleeman MA, Murphy AJ, Yancopoulos GD. Skokos D, et al. Sci Transl Med. 2020 Jan 8;12(525):eaaw7888. doi: 10.1126/scitranslmed.aaw7888. Sci Transl Med. 2020. PMID: 31915305
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.
Waite JC, Wang B, Haber L, Hermann A, Ullman E, Ye X, Dudgeon D, Slim R, Ajithdoss DK, Godin SJ, Ramos I, Wu Q, Oswald E, Poon P, Golubov J, Grote D, Stella J, Pawashe A, Finney J, Herlihy E, Ahmed H, Kamat V, Dorvilliers A, Navarro E, Xiao J, Kim J, Yang SN, Warsaw J, Lett C, Canova L, Schulenburg T, Foster R, Krueger P, Garnova E, Rafique A, Babb R, Chen G, Stokes Oristian N, Siao CJ, Daly C, Gurer C, Martin J, Macdonald L, MacDonald D, Poueymirou W, Smith E, Lowy I, Thurston G, Olson W, Lin JC, Sleeman MA, Yancopoulos GD, Murphy AJ, Skokos D. Waite JC, et al. Sci Transl Med. 2020 Jun 24;12(549):eaba2325. doi: 10.1126/scitranslmed.aba2325. Sci Transl Med. 2020. PMID: 32581132
Addendum.
Dimitris MC, Platt RW. Dimitris MC, et al. Paediatr Perinat Epidemiol. 2022 Nov;36(6):882. doi: 10.1111/ppe.12915. Epub 2022 Jul 17. Paediatr Perinat Epidemiol. 2022. PMID: 35844054 No abstract available.
The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability.
Ravn-Boess N, Roy N, Hattori T, Bready D, Donaldson H, Lawson C, Lapierre C, Korman A, Rodrick T, Liu E, Frenster JD, Stephan G, Wilcox J, Corrado AD, Cai J, Ronnen R, Wang S, Haddock S, Sabio Ortiz J, Mishkit O, Khodadadi-Jamayran A, Tsirigos A, Fenyö D, Zagzag D, Drube J, Hoffmann C, Perna F, Jones DR, Possemato R, Koide A, Koide S, Park CY, Placantonakis DG. Ravn-Boess N, et al. Cell Rep. 2023 Nov 28;42(11):113374. doi: 10.1016/j.celrep.2023.113374. Epub 2023 Nov 8. Cell Rep. 2023. PMID: 37938973 Free PMC article.
Photoreceptor-dependent regulation of photoprotection.
Allorent G, Petroutsos D. Allorent G, et al. Curr Opin Plant Biol. 2017 Jun;37:102-108. doi: 10.1016/j.pbi.2017.03.016. Epub 2017 May 1. Curr Opin Plant Biol. 2017. PMID: 28472717 Review.
Invited Commentary: Modern Epidemiology Confronts COVID-19-Reflections From Psychiatric Epidemiology.
Martínez-Alés G, Keyes K. Martínez-Alés G, et al. Am J Epidemiol. 2023 Jun 2;192(6):856-860. doi: 10.1093/aje/kwad045. Am J Epidemiol. 2023. PMID: 36843016
Dimitris et al. (Am J Epidemiol. 2022;191(6):980-986) outline how the coronavirus disease 2019 (COVID-19) pandemic has, with mixed results, put epidemiology under the spotlight. ...
Dimitris et al. (Am J Epidemiol. 2022;191(6):980-986) outline how the coronavirus disease 2019 (COVID-19) pandemic has, with mixed re …
Diemer and Swanson Reply to "Considerations Before Using Pandemic as Instrument".
Diemer EW, Swanson SA. Diemer EW, et al. Am J Epidemiol. 2021 Nov 2;190(11):2280-2283. doi: 10.1093/aje/kwab175. Am J Epidemiol. 2021. PMID: 34132326 Free PMC article.
Dimitris and Platt (Am J Epidemiol. 2021;190(11):2275-2279) take on the challenging topic of using "shocks" such as the severe acute respiratory system coronavirus 2 (SARS-CoV-2) pandemic as instrumental variables to study the effect of some exposure on some outcome. ...
Dimitris and Platt (Am J Epidemiol. 2021;190(11):2275-2279) take on the challenging topic of using "shocks" such as the severe acute …
Molecular Pathogenesis of Low-Grade Glioma.
Bready D, Placantonakis DG. Bready D, et al. Neurosurg Clin N Am. 2019 Jan;30(1):17-25. doi: 10.1016/j.nec.2018.08.011. Neurosurg Clin N Am. 2019. PMID: 30470401 Free PMC article. Review.
355 results